Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
1991-10-31
pubmed:abstractText
The prenylation of several proteins involved in oncogenesis and signal transduction plays an essential role in regulating their biological activities. Two distinct isoprenoids are known to be involved in this modification, the 15-carbon farnesyl and 20-carbon geranylgeranyl groups. Thus far, identified farnesylated proteins contain methionine or serine at the COOH terminus, while those modified by geranylgeranyl end in leucine. This report describes the characterization of an enzyme activity that transfers the geranylgeranyl group to candidate proteins. The enzyme, termed a "protein geranylgeranyltransferase," exhibits a marked preference for substrate proteins that contain leucine at the COOH terminus. In fact, the enzyme will efficiently modify a normally farnesylated protein, Ha-ras, if its COOH-terminal amino acid is switched from serine to leucine. Additional studies characterize this enzyme and suggest that it is responsible for the geranylgeranyl modification of a number of GTP-binding proteins (or their subunits) that contain a consensus prenylation sequence ending in leucine.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-1898776, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-1899909, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-1902099, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-1992464, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2013090, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2018975, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2116010, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2116011, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2123345, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2187294, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2194674, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2203759, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2569235, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2642744, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2661017, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2663468, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2682646, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-2684976, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-3088563, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-3170631, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-3290900, http://linkedlifedata.com/resource/pubmed/commentcorrection/1924324-5432063
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8631-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Enzymatic modification of proteins with a geranylgeranyl isoprenoid.
pubmed:affiliation
Section of Cell Growth, Regulation and Oncogenesis, Duke University Medical Center, Durham, NC 27710.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't